Some low-cost generic drugs that have helped restrain health care costs for decades are seeing unexpected price spikes of up to 8,000 percent, prompting a backlash from patients, pharmacists and now Washington lawmakers. Aaron Kesselheim, associate professor of medicine at Brigham and Women’s Hospital, is mentioned.
